Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole

Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole

US Patent 12060382 · Granted Aug 13, 2024

Estimated economic value: $65,942,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-frosting and anti-dew device for spectroscopic measurements2024
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-12021
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-12021
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-12021
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-12021
Method for resolution of baclofen salts2021
Crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic aci2016
Process for the preparation of and crystalline forms of optical enantiomers of m2016
Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-su2016
Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-su2016
Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic aci2016
Method of measuring scattering of X-rays, its applications and implementation de2016